Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-06-17

FDA Approved: FLUTICASONE PROPIONATE DISKUS — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

The FDA approved a supplemental application for Fluticasone Propionate Diskus, with Prasco Laboratories as sponsor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluticasone Propionate Diskus (Fluticasone Propionate)

Snippet

SUPPL AP for FLUTICASONE PROPIONATE DISKUS (FLUTICASONE PROPIONATE)